Superparamagnetic Chitosan Nanoparticles for a Vancomycin Delivery System: Optimized Fabrication and In Vitro...

Area of Science:

• Biomaterials Science
• Nanotechnology
• Pharmacology

Background:

• Chronic pyogenic osteoarthrosis requires effective treatment to manage infection and pain.
• Systemic administration of vancomycin can lead to critical side effects.
• Developing targeted drug delivery systems can improve therapeutic efficacy and reduce adverse events.

Purpose of the Study:

• To develop and optimize vancomycin-loaded superparamagnetic chitosan nanoparticles (Vm-SPMCNs).
• To evaluate the drug loading, encapsulation efficiency, and release profile of Vm-SPMCNs.
• To investigate the potential of Vm-SPMCNs for treating chronic pyogenic osteoarthrosis with reduced systemic toxicity.

Main Methods:

• Optimization of Vm-SPMCN preparation using orthogonal array design.
• Characterization of Vm-SPMCNs using Fourier transform infrared spectroscopy and particle size analysis.
• In vitro drug release studies under varying conditions, including magnetic stimulation.

Main Results:

• Optimized Vm-SPMCNs achieved a drug loading of 10.30% and encapsulation efficiency of 79.02%.
• Characterization confirmed successful binding of vancomycin to superparamagnetic chitosan nanoparticles (207.2 nm diameter).
• In vitro release demonstrated sustained vancomycin release for ten days, above minimum inhibitory concentration, modulated by magnetic fields.

Conclusions:

• Optimized Vm-SPMCNs provide a promising system for localized vancomycin delivery in osteoarthrosis treatment.
• The magnetic properties allow for controlled, noninvasive drug release modulation.
• This approach has the potential to enhance therapeutic outcomes while minimizing systemic side effects of vancomycin.